Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene

Blood

Volumn 88, Issue 12, 1996, Pages 4558-4567

  Cumming, Robert C ^b   Liu, Johnson M ^b   Youssoufian, Hagop ^b   Buchwald, Manuel ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FANCONI ANEMIA; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 0029857336     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4558.bloodjournal88124558     Document Type: Article

References (56)

1. Strathdee CA, Buchwald M: Molecular and cellular biology of Fanconi anemia. Am J Pediatr Hematol Oncol 14:177, 1992
2. Auerbach AD: Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731, 1993
3. Strathdee CA, Duncan MV, Buchwald M: Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1:196, 1992
4. Joenge H, Lo Ten Foe JR, Oostra AB, van Berkel CGM, Rooimans MA, Schroeder-Kurth T, Wegner RD, Gelle JJP, Buchwald M, Arwert F: Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood 86:2156, 1995
5. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992
6. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712 1994
7. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
8. Youssoufian H, Auerbach A, Verlander PC, Steimle V, Mach B: Identification of cytosolic proteins that bind to the Fanconi anemia complementation group C polypeptide in vitro. Evidence for a multimeric complex. J Biol Chem 270:9876, 1995
9. Youssoufian H: Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 97:2003, 1996
10. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H: Genetic control of programmed cell death in Drosophila. Science 264:677, 1994
11. Cowling GJ, Dexter TM: Apoptosis in the haemopoietic system. Phil Trans R Soc Lond B 345:257, 1994
12. Martin SJ, Green DR, Cotter TG: Dicing with death: Dissecting the components of the apoptosis machinery. Trends Biochem Sci 19:26, 1994
13. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
14. Jiang H, Kochlar DM: Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 46:333, 1992
15. Tomei LD: Apoptosis: A program for death or survival?, in Tomei DL, Cope FO (eds): Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1991, p 279
16. Cowan WM, Fawcett JW, O'Leary DM, Stanfield BB: Regressive events in neurogenesis. Science 225:1258, 1984
17. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson ND: Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262:695, 1993
18. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
19. Steiler H: Mechanisms and genes of cellular suicide. Science 267:1445, 1995
20. Raff MC: Social controls on cell survival and cell death. Nature 356:397, 1992
21. Koury MJ: Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 20:391, 1992
22. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DM: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
23. Rosselli F, Sanceau J, Wietzervin J, Moustacchi E: Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet 89:42, 1992
24. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E: Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 83:1216, 1994
25. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A: Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487, 1995
26. Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J: Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248, 1995
27. Segal GM, Magenis RE, Brown M, Keeble W, Smith TD, Heinrich MC, Bagby GC: Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 94:846 1994
28. Walsh CE, Neinhuis AW, Samulsky RJ, Brown MG, Miller JL, Young NS, Lui JM: Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 94:1440, 1994
29. Baffy G, Miyashita T, Williamson JR, Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J Biol Chem 268:6511, 1993
30. Fairnbairn LJ, Cowling GJ, Reipert BM, DexterTM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
31. Boise LH, Gonzalez-Garcia M, Postetna CE, Ding L, Lindsten T, Truka LA, Mao X, Nuñez G, Thompson CB: bcl-x, a bcl-2-regulated gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
32. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931, 1983
33. Metcalf D: Multi-CSF-dependent colony formation by cells of a murine hemopoietic cell line: Specificity and action of multi-CSF. Blood 65:357, 1985
34. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L: Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 69:359, 1988
35. Hendrie PC, Miyazaka K, Yang YC, Langefeld CD, Broxmeyer HE: Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line MO7e. Exp Hematol 19:1031, 1991
36. Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915, 1991
37. Karasuyama H, Melchers F: Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18:97, 1988
38. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
39. Walsh CE, Grompe M, Vanin E, Buchwald M, Young NS, Nienhuis AW, Lui JL: A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 84:453, 1994
40. Morgenstern JP, Land H: Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587, 1990
41. Heim RA, Lench NJ, Swift M: Heterozygous manifestations in four autosomal recessive cancer-prone syndromes: Ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome. Mutat Res 284:25 1992
42. Wevrick R, Clarke CA, Buchwald M: Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet 2:655, 1993
43. Krasnoshstein F, Buchwald M: Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients. Hum Mol Genet 5:85, 1996
44. Brady G, Billia F, Knox J, Hoang T, Kirsh IR, Voura EB, Hawley RG, Cumming R, Buchwald M, Siminovitch K, Miyamoto N, Boehmelt G, Iscove N: Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol 5:909, 1995
45. Gavish H, dos Santos C, Buchwald M: A Leu554-to-Pro sustitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. Hum Mol Genet 2:123, 1993
46. Yamashita T, Wu N, Kupfer G, Corless C, Joenje H, Grompe M, D'Andrea AD: Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 87:4424, 1996
47. Hockenberry D, Nuñez G, Milliman C, Schreiber R, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
48. Tanaka S, Saito K, Reed J: Structure-function analysis of the Bcl-2 oncoprotein. J Biol Chem 268:10920, 1993
49. Jacobson M, Burnett J, King M, Miayashita T, Reed J: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365, 1993
50. Hockenbery DM, Oltvai ZN, Yin X, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
51. Nuñez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
52. Otani H, Erdos M, Leonard WJ: Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J Biol Chem 268:22733, 1993
53. Vanhaesebroeck B, Reed JC, DeValck D, Grooten J, Miyashita T, Tanaka S, Beyaert R, Van Roy F, Fiers W: Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene 8:1075, 1993
54. Bagby GC, Kenney N, Rathbun K, Keeble W, Tower P: The C-type Fanconi anemia complementing gene encodes a protein that slows the death rate of factor-deprived hematopoietic cells in-vitro. Blood 84:14a, 1994 (abstr, suppl 1)
55. Kruyt FAE, Dijkmans LM, van den Berg TK, Joenge H: Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 87:938, 1996
56. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991